Published in

Translational Cancer Research, S3(5), p. S590-S594

DOI: 10.21037/tcr.2016.09.31

Links

Tools

Export citation

Search in Google Scholar

Bendamustine and rituximab for the treatment of relapsed indolent and mantle cell lymphoma: when timing of a study matters

Journal article published in 2016 by Lorenzo Falchi ORCID, Rita Morales, Marco Ruella
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload